Future drug developments in multiple myeloma: an overview of novel lenalidomide-based combination therapies
{{output}}
The introduction of thalidomide, lenalidomide, and bortezomib has changed the way that multiple myeloma (MM) is treated and has greatly improved survival outcomes. These novel agents are often used in combination with conventional drugs, such as dexamethasone,... ...
